Nuclear Mitotic Apparatus Protein 1 (NUMA1) Peptide
NUMA1
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
Catalog No. ABIN936841
Quick Overview for Nuclear Mitotic Apparatus Protein 1 (NUMA1) Peptide (ABIN936841)
Target
NUMA1
(Nuclear Mitotic Apparatus Protein 1 (NUMA1))
Origin
Mammalian
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Peptide Type
- Synthetic
-
Sequence
- AQRLQAQLNE LQAQLSQKEQ AAEHYKLQME KAKTHYDAKK QQNQELQEQL
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of NUMA1 antibody,
Alternative Names: NUMA1 control peptide, NUMA1 antibody Blocking Peptide, Anti-NUMA1 Blocking Peptide, nuclear mitotic apparatus protein 1 Blocking Peptide, NUMA Blocking Peptide, NUMA1, NUMA-1, NUMA 1, NUMA-1 Blocking Peptide, NUMA 1 Blocking Peptide -
Purification
- Immunoaffinity chromatography
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- NUMA1 (Nuclear Mitotic Apparatus Protein 1 (NUMA1))
-
Background
- NuMA is a structural element in maintaining nuclear integrity. A critical spindle pole-associated mechanism, called the END (Emi1/NuMA/dynein-dynactin) network, spatially restricts APC/C activity in early mitosis. The entire coding region and exon-intron boundaries of NuMa were screened in 92 familial breast cancer patients. But the results do not support the role of NuMA variants as breast cancer susceptibility alleles.
-
Molecular Weight
- 238 kDa
Target
-
You are here:
